Log in to save to my catalogue

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-anal...

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-anal...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_234710

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

About this item

Full title

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Publisher

England: Elsevier Ltd

Journal title

Lancet neurology, 2016-06, Vol.15 (7), p.673-684

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Alzheimer's disease biomarkers are important for early diagnosis in routine clinical practice and research. Three core CSF biomarkers for the diagnosis of Alzheimer's disease (Aβ42, T-tau, and P-tau) have been assessed in numerous studies, and several other Alzheimer's disease markers are emerging in the literature. However, ther...

Alternative Titles

Full title

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_234710

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_234710

Other Identifiers

ISSN

1474-4422,1474-4465

E-ISSN

1474-4465

DOI

10.1016/S1474-4422(16)00070-3

How to access this item